第三屆國際生物制藥項(xiàng)目和技術(shù)交流會將在滬舉辦
瀏覽次數(shù):5194 發(fā)布日期:2012-7-31
來源:本站 本站原創(chuàng),轉(zhuǎn)載請注明出處
Biologics World China 2012
第三屆國際生物制藥項(xiàng)目和技術(shù)交流會
http://www.imapac.com/index.php?page=BiologicsWorldChina2012
5-7 November 2012, Shanghai, China
Produced and organised by IMAPAC
China’s biggest and most influential gathering of biopharmaceutical companies!
IMAPAC's 3rd ANNUAL Biologics World China continues to provide an industry-focused platform in China, bringing together decision makers across C level management, R&D and Manufacturing in the realms of Biologic drugs, Biosimilars, Vaccines and Blood/Plasma products!
Over 300 industry experts will gather to share best practices and exchange perspectives on raising benchmark of quality, stimulating innovation and increasing global competitiveness. Regulatory guidelines, parameters for biosimilars, case studies on cell lines and process development, scale-up and downstream methodologies, single-use technology and a showcase of novel biologics and vaccines will be featured in the 2012 show.
It will be a one-stop solution for you to reach out to China's burgeoning biologics market!
International featured speakers include:
- Dr Joe Zhou, Chief Executive Officer, Genor BioPharma, China
- Dr Ke Wu, President and Founder, BravoBio, China
- Dr Michael Yu, CEO, Innovent Biologics, China
- Dr Klaus Kaiser, Senior Scientist, Global Biologics - Biotech Development, Bayer Pharma, Germany
- Dr Allan Riting Liu, Vice President, Wanbang Biopharma, China
- Robert Chen, Senior Director, Global Strategy and Partnering, Genor Biopharma, China
- Dr Saul Mashaal, Chairman, Acertus Pharma, USA and Co-Chair, Vanir BioVice, Singapore
- Zoe Wang, Partner, June He Law Offices, China
- Dr Jin-San Yoo, President and CEO, PharmAbcine, South Korea
- Dr Scott Liu, CEO, Henlius Biopharmaceuticals Inc, China
- Lily Peng, Chairman, Chinese-Taipei Biotechnology Service Association, Taiwan
- Dr Ming Wang, President and COO, Gan & Lee Pharma, China
- Dr Jiang Fei, Research and Development, 3sBio, China
- Jian Dong, Vice President, Shanghai Celgen Bio-pharmaceutical, China
- Dr Yong Yin, CSO, R&D, Shanghai MT Biotech Co. Ltd, China
- Helen Yang, Director Investor Relations and International Business Development, Sinovac Biotech Ltd, China
- Zhao Chao Ming, Chief Executive Officer, China Biologic Products, China
- Dr Feng Li, CEO, Beijing Mab-Works, China
Registration details:
Sponsorship or exhibition opportunities:
Limited sponsorship and exhibition opportunities, so contact Aylene Vicmudo at aylene.vicmudo@imapac.com or +65 6493 1597
- Contact Point: Patricia Chong at patricia.chong@imapac.com or +65 6493 1871